
Backs early-phase formative-stage companies.
- Cheque size
- $1M – $5M
- Stages
- Industries
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

Backs early-phase formative-stage companies.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Digital security-focused, operator-led firm that co-founds and incubates formative-stage companies alongside world-class technologists, presenting hands-on founder support from leaders who've built flagship security companies.
Specializes entirely on AI-first businesses in technical domains (defense, robotics, drug discovery, AI infrastructure), utilizing the entrepreneur’s extensive AI analysis visibility and a press arm that fosters lab-to-lab debates.